Summary
Streptozotocin-diabetic rats were maintained on a 72% fructose diet for 4 weeks and some were treated with an aldose reductase inhibitor (either alrestatin: 0.9 g · kg−1 · day−1 or ONO-2235: 50 mg · kg−1 · day−1). Fructose feeding significantly influenced the development of impaired motor nerve conduction velocity in the diabetic rats and this effect was positively correlated with sorbitol accumulation in the sciatic nerve of diabetic rats maintained on a fructose-rich diet. Treatment with ONO-2235, a new aldose reductase inhibitor, prevented both slowing of motor nerve conduction velocity and elevation of nerve sorbitol concentration. On the other hand, erythrocyte sorbitol levels were significantly correlated to those of the sciatic nerve (r=0.86, p<0.001) and the retina (r=0.91, p<0.001) in these animals. Thus, our findings suggest that increased polyol pathway activity may be related to the pathogenesis of diabetic neuropathy and erythrocyte sorbitol concentrations may prove a useful indicator for the presence of diabetic complications.
Article PDF
Similar content being viewed by others
References
Dvornik D, Simard-Duquesne N, Krami M, Sestanj K, Gabbay KH, Kinoshita JH, Varma SD, Merola O (1973) Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science 182: 1146–1148
Hotta N, Kakuta H, Kamei I, Kimura M, Fukasawa H, Koh N, Sakamoto N (1982) Effect of fructose-enriched diet and aldose reductase inhibitor in the development of diabetic complications. Diabetes (Suppl 2): 10A
Hotta N, Kakuta H, Kamei I, Kimura M, Fukasawa H, Koh N, Sakamoto N, Matsuoka Y, Iida M (1982) The effect of fructose diet on diabetic nerve. In: Goto Y, Horiuchi A, Kogure K (eds) Proceedings of the International Symposium on Diabetic Neuropathy and its Treatment, Tokyo. Excerpta Medica, Amsterdam, International Congress Series 581: 109–113
Tomlinson DR, Holmes PR, Mayer JH (1982) Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 31: 189–193
Yue DK, Hanwell MA, Satchell FM, Turtle JR (1982) The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rat. Diabetes 31: 789–794
Gillon KRW, Hawthorne JN, Tomlinson DR (1983) Myoinositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia 25: 365–371
Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T, Tsuboshima M (1983) Effects of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene] rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia 24: 290–292
Fugius J, Jameson S (1981) Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy — a clinical and neurophysiological study. J Neurol Neurosurg Psychiatr 44: 991–1001
Handelsman DJ, Turtle JR (1981) Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30: 459–464
Hotta N, Kakuta H, Kimura M, Fukasawa H, Koh N, Terashima H, Iida M, Sakamoto N (1983) Experimental and clinical trial of aldose reductase inhibitor in diabetic neuropathy. Diabetes (Suppl 2): 98A
Jaspan JB, Mafelli R, Herold K, Bartkuf C (1983) Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet 2: 758–762
Judzewitsch RG, Jaspan JB, Polonsky KS, Weinberg CR, Halter JB, Halar E, Pfeifer MA, Vukadinovic C, Bernstein L, Schneider M, Liang K-Y, Gabbay KH, Rubenstein AH, Porte Jr D (1983) Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med 308: 119–125
Cohen AM, Teitelbaum A, Rosenman E (1977) Diabetes induced by a high fructose diet. Metabolism 26: 17–24
Hotta N, Kakuta H, Kunieda T, Ida A, Tamagawa T, Kojima K, Sakamoto N (1982) Influence of fructose on the development of vascular disease in diabetes. In: Melish JS, Hanna J, Baba S (eds) Proceedings of the Third Symposium on Diabetes Mellitus in Asia and Oceania, Hawaii. Excerpta Medica, Amsterdam, International Congress Series 549: 344–347
Gabbay KH (1973) The sorbitol pathway and the complications of diabetes. N Engl J Med 288: 831–836
Hotta N, Kakuta H (1981) Pathogenesis of diabetic retinopathy from aspects of retinal metabolism. J Japan Diab Soc 24: 1100–1103
Miyoshi T, Goto I (1973) Serial in vivo determinations of nerve conduction velocity in rat tails: physiological and pathological change. Electroencephalogr Clin Neurophysiol 35: 125–131
Bergmeyer HU, Bernt E, Schmidt F, Stock H (1974) D-Glucose. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1196–1201
Bergmeyer HU, Gruber W, Gutmann I (1974) D-Sorbitol. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1323–1326
Bernt E, Bergmeyer HU (1974) D-Fructose. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1304–1307
Malone JI, Knox G, Benford S, Tedesco TA (1980) Red cell sorbitol. An indicator of diabetic control. Diabetes 29: 861–864
Clements RS (1979) Diabetic neuropathy: new concepts of its etiology. Diabetes 28: 604–611
Greene DA (1983) Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism 32: 118–123
Hotta N, Tersahima H, Sakamoto N: Unpublished data
Förster H (1974) Comparative metabolism of xylitol, sorbitol, and fructose. In: Sipple HL, McNutt KW (eds) Sugars in nutrition. Academic Press, New York, San Francisco, London, pp 259–280
Morrison AD, Clements RS Jr., Travis SB, Oski F, Winegrad AI (1970) Glucose utilization by the polyol pathway in human erythrocytes. Biochem Biophys Res Commum 40: 199–205
Jakobsen J (1978) Peripheral nerve in early experimental diabetes: expansion of the endoneural space as a cause of increased water content. Diabetologia 14: 113–119
Gabbay KH (1975) Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Ann Rev Med 26: 521–536
Mayer JH, Tomlinson DR (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia 25: 433–438
Peterson MJ, Sarges R, Aldinger CE, McDonald DP (1979) CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism 28 (Suppl 1): 456–461
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hotta, N., Kakuta, H., Fukasawa, H. et al. Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. Diabetologia 28, 176–180 (1985). https://doi.org/10.1007/BF00273868
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00273868